Catalent Pharma Solutions

Articles

Various impurities can infiltrate the container closure system in pharmaceutical manufacturing. Understanding nitrosamines, elemental impurities, extractables, and leachables can help ensure the safety of the final product. 

Nitrosamines, Elemental Impurities, Extractables, and Leachables: The Pharma Industry’s New Normal

Lipid-based formulations can improve the oral bioavailability of some molecules. However, a poor understanding of the technology and complexities limit their use.

Key Considerations in Using Lipid-Based Formulations: Preclinical Toxicology vs Clinical

It is essential to have access to the right tools and expertise to support process development for biologic therapies, from the clinical trial phase to commercialization.

Process Optimization for mAb Commercial Manufacturing

Modern mathematical and computerized modelling tools can improve scale-up and efficiency of continuous manufacturing of oral solid dosage drugs.

Today's Modelling Tools for Small Molecule Solid Dose Manufacturing

A company focused on the treatment of advanced solid tumors, partnered with Catalent for the development, clinical trial supply and scale-up of a spray-drying program. 

Enabling Successful SDD Scale Up (Sept 2023)

Discover how to use enteric polymer coatings effectively for controlled drug delivery in oral medications to enhance your drug formulations.